Scarica l'app Stockscreener
652.27
0.02%
0.16
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché IDXX Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$652.11
Aprire:
$652.79
Volume 24 ore:
467.97K
Relative Volume:
0.77
Capitalizzazione di mercato:
$52.18B
Reddito:
$4.04B
Utile/perdita netta:
$985.66M
Rapporto P/E:
54.31
EPS:
12.01
Flusso di cassa netto:
$774.34M
1 W Prestazione:
+1.61%
1M Prestazione:
+22.29%
6M Prestazione:
+42.62%
1 anno Prestazione:
+35.91%
Intervallo 1D:
$647.38
$654.36
Intervallo di 1 settimana:
$623.40
$665.52
Portata 52W:
$356.14
$688.12
Idexx Laboratories Inc Stock (IDXX) Company Profile
Nome
Idexx Laboratories Inc
Settore
Industria
Telefono
(207) 556-0300
Indirizzo
ONE IDEXX DRIVE, WESTBROOK, ME
Confronta IDXX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
IDXX
Idexx Laboratories Inc
|
652.27 | 52.17B | 4.04B | 985.66M | 774.34M | 12.01 |
|
TMO
Thermo Fisher Scientific Inc
|
477.41 | 174.60B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
205.72 | 143.04B | 24.01B | 3.41B | 4.86B | 4.70 |
|
A
Agilent Technologies Inc
|
117.32 | 32.42B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
185.91 | 30.62B | 15.50B | 1.33B | 2.16B | 7.34 |
Idexx Laboratories Inc Stock (IDXX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-05 | Reiterato | BTIG Research | Buy |
| 2025-07-01 | Iniziato | Jefferies | Buy |
| 2024-12-02 | Iniziato | Leerink Partners | Outperform |
| 2024-07-25 | Iniziato | BTIG Research | Buy |
| 2024-01-30 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2023-12-07 | Iniziato | Exane BNP Paribas | Outperform |
| 2023-12-04 | Aggiornamento | Cleveland Research | Neutral → Buy |
| 2023-08-02 | Downgrade | Atlantic Equities | Overweight → Neutral |
| 2022-07-25 | Downgrade | Stifel | Buy → Hold |
| 2022-07-21 | Aggiornamento | Goldman | Neutral → Buy |
| 2022-07-12 | Iniziato | Piper Sandler | Overweight |
| 2022-05-05 | Downgrade | BofA Securities | Buy → Neutral |
| 2022-02-08 | Iniziato | Atlantic Equities | Overweight |
| 2021-11-18 | Iniziato | Morgan Stanley | Overweight |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2021-07-12 | Downgrade | Guggenheim | Buy → Neutral |
| 2021-02-17 | Iniziato | Barclays | Overweight |
| 2019-09-09 | Iniziato | Goldman | Neutral |
| 2019-05-23 | Iniziato | Guggenheim | Buy |
| 2018-11-02 | Reiterato | BofA/Merrill | Buy |
| 2018-05-07 | Reiterato | Stifel | Buy |
| 2018-01-16 | Iniziato | Piper Jaffray | Overweight |
| 2017-08-23 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2017-07-28 | Aggiornamento | CL King | Neutral → Buy |
| 2017-02-03 | Downgrade | Feltl & Co. | Hold → Sell |
| 2016-09-29 | Ripresa | BofA/Merrill | Neutral |
| 2016-08-16 | Reiterato | Stifel | Buy |
| 2016-08-03 | Aggiornamento | Northcoast | Sell → Neutral |
| 2016-07-20 | Reiterato | Canaccord Genuity | Buy |
| 2016-04-19 | Reiterato | Canaccord Genuity | Buy |
| 2016-04-01 | Iniziato | CL King | Neutral |
| 2016-03-21 | Reiterato | Stifel | Buy |
| 2016-02-04 | Iniziato | Credit Suisse | Outperform |
| 2015-10-29 | Reiterato | Stifel | Buy |
| 2015-08-28 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2015-08-13 | Reiterato | Stifel | Buy |
| 2015-07-23 | Reiterato | Canaccord Genuity | Buy |
Mostra tutto
Idexx Laboratories Inc Borsa (IDXX) Ultime notizie
Here's How Much a $1000 Investment in Idexx Laboratories Made 10 Years Ago Would Be Worth Today - Yahoo Finance
A Closer Look at IDEXX Laboratories's Options Market Dynamics - Benzinga
IDEXX Laboratories' 15min chart: RSI Overbought, KDJ Death Cross triggered. - AInvest
IDEXX Laboratories: Piper Sandler Raises PT to $700 from $510 - AInvest
Is Now An Opportune Moment To Examine IDEXX Laboratories, Inc. (NASDAQ:IDXX)? - 富途牛牛
IDEXX Laboratories (NASDAQ:IDXX) Stock Price Expected to Rise, BTIG Research Analyst Says - MarketBeat
IDEXX Laboratories Inc(IDXX.US) Officer Sells US$5.28 Million in Common Stock - 富途牛牛
IDEXX Labs Volume Plummets 28% as Veterinary Diagnostics Stock Slides to 256th in U.S. Trading Activity Rankings - AInvest
IDEXX Laboratories (NASDAQ:IDXX) Price Target Raised to $675.00 at JPMorgan Chase & Co. - MarketBeat
Here's Why Idexx Laboratories (IDXX) is a Strong Growth Stock - Yahoo Finance
How Idexx Laboratories Is Riding The 'Puppy Boom' To New Highs - MSN
IDEXX’s Healthy Streak Outpaces The Pack In Animal Care - Finimize
IDEXX Laboratories shares rise 3.10% intraday after Rothschild & Co Redburn raised price target to $670. - AInvest
IDEXX Laboratories, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next - Yahoo Finance
IDEXX Laboratories, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions - simplywall.st
Decoding IDEXX Laboratories Inc (IDXX): A Strategic SWOT Insight - GuruFocus
Tesla, Delta Air, IDEXX Laboratories Among CNBC's 'Final Trades' - AInvest
BTIG Boosts Idexx Laboratories Price Target to $785 Amid Strong Q2 Earnings - AInvest
Leerink Partners Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating, Raises Target Price to $745 - 富途牛牛
Why Idexx Laboratories (IDXX) is a Top Momentum Stock for the Long-Term - Yahoo Finance
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q2 2025 Earnings Call Transcript - Insider Monkey
Why a Company You’ve Never Heard of Is One of the Best Nasdaq-100 Stocks of the Year - inkl
IDEXX strengthens competitive edge in veterinary diagnostics - MarketScreener
IDEXX Laboratories stock price target raised to $785 from $625 at Jefferies - Investing.com India
Idexx Laboratories: Strong Financial Performance and Strategic Outlook Justify Buy Rating - TipRanks
IDEXX Executives Make Major Stock Trades on August 6 - AInvest
IDEXX Laboratories Reports Strong Q2 2025 Results - The Globe and Mail
IDEXX Laboratories’ Earnings Call Highlights Strong Growth - TipRanks
Is the Market Bullish or Bearish on IDEXX Laboratories? - 富途牛牛
A Quick Look at Today's Ratings for IDEXX Laboratories Inc(IDXX.US), With a Forecast Between $626 to $785 - 富途牛牛
Jefferies Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating, Raises Target Price to $785 - 富途牛牛
Tesla, Delta Air, IDEXX Laboratories And More On CNBC's 'Final Trades' - Benzinga
BNP Paribas Exane Adjusts PT on IDEXX Laboratories to $761 From $577, Maintains Outperform Rating - MarketScreener
Morgan Stanley Adjusts PT on IDEXX Laboratories to $722 From $626, Maintains Overweight Rating - MarketScreener
IDXX Surpasses Analyst Target Price of $558.30 - AInvest
Axon Enterprise, Berkshire Hathaway, Idexx Laboratories - TradingView
IDEXX Laboratories Inc (IDXX) Q2 2025 Earnings Call Highlights: Strong Revenue and EPS Growth ... - Yahoo Finance
Idexx: Q2 Earnings Snapshot - Norwalk Hour
IDEXX Laboratories Inc (IDXX) Q2 2025 Earnings Call Highlights: Strong Revenue and EPS Growth ... By GuruFocus - Investing.com Canada
IDEXX Laboratories Soars: A New Benchmark for Animal Health Diagnostics - FinancialContent
IDEXX Laboratories' Price Target Raised to $675 by JP Morgan, Maintains Overweight Rating - AInvest
JPMorgan Boosts Idexx Laboratories' Price Target to $675, Maintains Overweight Rating - AInvest
BofA Boosts Price Target for Idexx Laboratories to $700 Amid Robust Q2 Performance - AInvest
IDEXX Laboratories Surges on Raised Revenue and Profit Forecasts, Analysts Mixed on One-Year Price Target - AInvest
Stifel Raises Idexx Laboratories Price Target to $640, Keeps Hold Rating - AInvest
Research Alert: CFRA Maintains Buy Opinion On Shares Of Idexx Laboratories, Inc. - 富途牛牛
IDEXX Laboratories Surges on Price Target Adjustments and New Board Member - timothysykes.com
Log Commercial 2Q net revenue R$61.5M, estimate R$60.3M - AInvest
IDEXX Labs Stock Sparks Interest: Analyzing Market Buzz - timothysykes.com
IDEXX LABORATORIES INC /DE SEC 10-Q Report - TradingView
U.S. Indexes Moved Upward Monday; IDEXX Laboratories Led Increases - Barron's
Idexx Laboratories Inc Azioni (IDXX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.80%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):